November 30,2000 Via Federal Express U li PLAINTIFFS EXHIBIT CAM-269 Dr.

c f THE COSMETIC, TOILETRY, AND FRAGRANCE ASSOCIATION April 24, 2001 Dr.

Pag 1 ol 4 MATERIAL SAFETY DATA SHEET Jm e I. 2006 Group MtSTRON PLUS* LU ZEN AC A M E R IC A INC. 345 Inverness Drive South C entennial.

Policy Watch Carcinogenicity of carbon black, titanium dioxide, and talc Robert Baan, Kurt Straif Yarn Grasse, Beatrice SeCretan, Fatiha El Ghissassi, Vincent Cogliano, on behalf of the WHO International Agency for Research on Cancer Monograph Working Group In February, 2006, 19 scientists from eight countries met atthe International Agency for Research on Cancer (IARC), Lyon, France, to reassess the carcino genicity of carbon black, titanium dioxide, and non-asbestiform talc.

p 3 v^ DEPARTMENT OF HEALTH.

REDACTED DOCUMENT ri PLEAXIHNITBIIFTFS CAM-261 ----- ------ Phelps Dodge Corporation Ext Ref 0000000 P % , Cyprus Minerals Company and RTZ America Inc - 5 01/58704 2001/58704 2001/58704 i <?

MEMBER AGIL Sani-Pure Food Laboratories CHEMISTS TO THE FOOD INDUSTRIES 178-182 Saddle River Road Saddle Brook, New Jersey 07663-4619 VOICE (201)843-2525 FAX (201) 843-4934 E-MAIL sanipure.labs@verlzon.net Certificate of Laboratory Analysis PLAINTIFF'S EXHIBIT CAM-346 Luzenac America John Poston 17509 Van Road Houston, TX 77049 Date Received: Date Reported: Lab Number: Page: 1/19/05 1/24/05 05,019,c,302 1 of 3 Product Identification Grind Date Ship Name Luzenac Guangxi #2 1/18/2005 M.V.

Personal C are Products Counci Committed to Safety, Q u ality & Innovation July 21, 2009 Division of Dockets Management Food and Drug Administration Room 1061 5630 Fishers Lane Rockville, MD 20852 R E : Comments on: Citizens Petition to the Commissioner of the Food and Drug Administration Seeking a Cancer Warning on Talc Products Docket FDA-2008-P-0309 Dear Division of Dockets Management: The Personal Care Products Council1(the Council) appreciates the opportunity to comment on the above referenced Citizens Petition.

KMTSit n t o re rtcpcr. ^ ' D rli O ctober 31 5 T1..

# ATTACHMENT A D escription of Modified Method to R ev ise Proposed Section 1 2 1 .2006(c) (2) Determine the Nz of the talc.

Research report Downloaded from jech.bmj.com on 3 0 M ay 2 0 0 8 Perineal use of talc and risk of ovarian cancer H Langseth,1 S E Hankinson,2 J Siemiatycki,3 E W eiderpass145 1The Cancer Registry of Norw ay, Institute of populationbased Cancer Research, Oslo, Norway; 2 Channing Laboratory, Department of Medicine, Brigham and W o m e n 's Hospital and Harvard Medical School, Boston, M A , U S A ; 3 Department of Social and Preventive Medicine, University of Montreal, Montreal, Canada; 4 Department of Medical Epidemiology and Biostatistics, Karolinska Instituted Stockholm, Sweden; 5 Samfundet Folkhalsan, Helsinki, Finland Correspondence to: E Weiderpass, The Cancer Registry of Norway, 0 3 1 0 Oslo, Norway; eliwei@ki.se Accepted 15 October 2007 ABSTRACT Ovarian cancer is one of the most common gynaecological neoplasms, especially in industrialised countries.

FEB. 7.2000 12:3am miTTPKER/ CLARK&DflNIELS NO.58a P.2 HAY 2 4 2Q0. 9g Q - / S 'V WHITTAKER.

) Int.

1133 STREET, N.W., WASHINGTON, D C. 2005 202/331-1770 TELEX 69-2673 M EMR ANDM James H.PrMreiHreitrU* Morm'an F.

Memorandum to: From: Subject: The Hearing Clerk Food and Drug Administration Room 6 - 8 6 5600 Fishers Lane ROCKVILLE, Md. 20852, U.S.A.